Trump expands Section 232 tariffs to steel, aluminum, copper, and pharmaceuticals
Updated
Updated · Lawfare blog · Apr 28
Trump expands Section 232 tariffs to steel, aluminum, copper, and pharmaceuticals
9 articles · Updated · Lawfare blog · Apr 28
The new regime imposes 50% tariffs on raw metals, 25% on derivative products, and up to 100% on on-patent drug imports, with exemptions for certain countries and companies.
Trump's changes simplify tariff structures, broaden product coverage, and pressure pharmaceutical firms to strike deals for tariff relief, while legal challenges face uphill battles due to broad presidential authority under Section 232.
These actions follow the Supreme Court's February ruling limiting IEEPA tariffs, prompting Trump to rely on Section 232, and raise concerns about executive power in trade policy and calls for greater congressional oversight.
With IEEPA tariffs voided, will the estimated $175 billion in refunds strain the U.S. Treasury?
Will linking pharma tariffs to MFN pricing actually lower drug costs for American consumers?
Are common appliances legally considered 'derivative products' under the new metals tariff regime?
How will U.S. tariffs on AI chips from Taiwan reshape the global semiconductor arms race?
As Section 232 targets more industries, is Congress losing its constitutional power over trade?
Is 'national security' now a justification for broad economic and industrial policy?